The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome

• Published in: Endocrine Connections Vol. 9; no. 6; pp. 563 - 569
• Main Authors: Javed, Zeeshan, Papageorgiou, Maria, Madden, Leigh A, Rigby, Alan S, Kilpatrick, Eric S, Atkin, Stephen L, Sathyapalan, Thozhukat
• Format: Journal Article
• Language: English
• Published: England Bioscientifica Ltd 01.06.2020; Bioscientifica
• Subjects: empagliflozin; endothelial microparticles; metformin; polycystic ovary syndrome; sglt2 inhibitors; empagliflozin; endothelial microparticles; metformin; polycystic ovary syndrome; SGLT2 inhibitors

Context Endothelial microparticles (EMPs) are novel, surrogate biomarkers of endothelial function and have been shown to be elevated in women with polycystic ovary syndrome (PCOS). It remains poorly understood how pharmacological options for managing PCOS affect EMP levels. Objective To characterise...